ArticleBMC medical imaging2025
Correlation between hemodynamic characterizations of cervical arteries and changes in cerebral microcirculation under dobutamine stress: a self-controlled study.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDobutamine, an inotropic agent, is known to enhance cardiac function. However, its concurrent effects on cervical artery hemodynamics and cerebral microcirculation, along with their potential correlation, remain unclear. This study aimed to investigate these relationships in healthy volunteers under dobutamine stress.
methodsIn this self-controlled study, cervical artery hemodynamic parameters, including vessel diameters, peak systolic velocity, end-diastolic velocity (EDV), mean flow velocity (MV), resistance index and pulsatility index of cervical arteries parameters of 20 healthy volunteers were obtained via ultrasound. Whole-brain cerebral blood flow (wCBF_ASL) and cerebral blood flow in regions of interest (CBF_ROI) were obtained by magnetic resonance imaging using arterial spin labeling before and during the dobutamine stress test. Blood flow (BF) in the cervical arteries were calculated from the MV and the vessel diameter. Ultrasound-derived cerebral blood flow (CBF_US) was defined as the sum of the BF from the left and right internal carotid arteries (ICA) and the vertebrobasilar artery.
resultsOverall cerebral blood flow, measured by both CBF_US and wCBF_ASL, remained unchanged during dobutamine stress (P > 0.05). However, dobutamine induced significant reductions in CBF_ROI in specific regions, including the right middle temporal pole, left middle temporal pole, and left cerebellum (P < 0.05). Notably, linear regression analysis revealed that the change in EDV of the right internal carotid artery (ICA-R) was a significant positive predictor of the CBF change in the right middle temporal pole (B = 0.32, p = 0.042).
conclusionsDobutamine administration can induce regional cerebral hypoperfusion despite stable global cerebral blood flow. Alterations in ICA hemodynamic parameters are correlated with these regional perfusion deficits. These findings suggest that monitoring cervical artery hemodynamics during dobutamine administration may offer insights into regional cerebral perfusion changes, and could potentially be explored as a complementary tool for risk stratification in patients undergoing dobutamine stress tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.